Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The usual treatment for obstructive airway disease (OAD) after allogeneic hematopoietic stem
cell transplantation (AHSCT) , which is related to graft versus host disease (GVHD), consists
of intensification of systemic immunosuppressive therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborator:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate